Skip to main content

Medical Products Bill tracker

The Medical Products Bill will replace the Medicines Act 1981 with a modern, risk-proportionate framework for medicines and medical devices. This page tracks its progress.

Source

Information on this page is drawn from Ministry of Health publications at health.govt.nz and Cabinet papers released publicly.


Status overview

StageStatus
Decision to develop the Bill✅ Complete — September 2024
Key policy settings agreed✅ Ongoing — multiple Cabinet rounds
SaMD and innovation provisions agreed✅ Complete — July 2025
Draft Bill publicly released🔄 Expected late 2025
Parliamentary introduction🔄 Expected during current term
Select Committee consideration⏳ Not yet
Enactment⏳ Not yet
Transition period / commencement⏳ Not yet

Key confirmed policy decisions

DecisionDateDetail
Medsafe continues as regulatorSep 2024
Independent statutory officerSep 2024Appointed by Director-General of Health
Cost-recovery model retainedSep 2024With new levy-setting power
Export-only products excluded2024No NZ approval needed for export-only
SaMD regulatedJul 2025IMDRF-aligned definition
General clinical software excludedJul 2025Not a medical device
AI for therapeutic purposes includedJul 2025Regulated as SaMD
Risk-based clinical trialsJul 2025Low-risk notify only; high-risk require approval
All trials need ethics approvalJul 2025Unchanged from current

What to watch

  • Pre-market approval pathways for devices — the specific routes and requirements have not yet been confirmed in detail
  • Transition arrangements — how existing WAND notifications will transition to any new approval framework
  • UDI requirements — whether NZ will introduce UDI under the new Bill
  • PSUR and PMS requirements — whether formal periodic reporting will be introduced
  • IVD regulation — whether IVDs will continue to be exempt or will require formal approval

How to stay informed